GENESIS Biomed participated in the strategic development of AptaTargets, which has licensed its drug ApTOLL to Merck ... 30 October, 2025
GENESIS Biomed, sponsor of BIOSPAIN 2025, has been involved in the event with active participation ... 16 October, 2025
Rafael Navajo – Director of Innovation and Business Development Area at VHIR (Vall d’Hebron Research Institute) ... 18 September, 2025
GENESIS Biomed participated in the valuation of CellsIA, a company acquired by Laboratorios ROVI ... 19 June, 2025
